News | March 01, 2011

European Cardiac Rhythm Management Market Expected to Double by 2017

March 1, 2011 – Medtronic, St. Jude Medical and Biotronik have emerged as leaders in the €2.8 billion European cardiac rhythm management (CRM) electrophysiology and ablation market, according to iData Research. The companies have been particularly successful in the telehealth monitoring for cardiac implantable electric devices (CIEDs).

By 2017, the CIEDs market is expected to grow at double-digit rates. Cardiac resynchronization therapy (CRT) devices were the fastest growing in 2010 and sales will reach over €1 billion due to recent technological advances in wireless connectivity and miniaturization. By 2017, the total European CRM, electrophysiology and ablation markets are expected to reach over €4.4 billion.

"Improved technologies are leading to increased diagnosis rates of cardiac arrhythmias in Europe," said Kamran Zamanian, Ph.D. CEO of iData. "This will drive the market for diagnostic electrophysiology stimulators, recorders and catheters, as well as the market for cardiac resynchronization therapy. Both of these markets are expected to almost double in value by 2017."

The report states that in 2010, the U.K. exhibited the fastest growth per-capita in CRM device implantation. This was due to National Health Service (NHS) targets to increase the use of implantable cardioverter defibrillators (ICD) and CRT devices in order to reach a per-capita level similar to the European average. In addition, pilot programs for the use of remote monitoring have stimulated growth of telehealth monitoring for CIEDs.

Furthermore, the report states that Medtronic was the leader in the overall cardiac rhythm management market including telehealth monitoring for CEIDs. St. Jude, Boston Scientific and Biotronik were also top manufacturers.

For more information:?

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
Overlay Init